Browse the evidence

The WIG scoring algorithm assigns points based on specific criteria related to weight loss and metabolic markers.

Healthcare providers can utilize the WIG scoring criteria to assess patient eligibility for medication dose reduction.

Rapid weight loss leads to dehydration in MMA athletes.

Athletes should be aware of the risks of dehydration when engaging in rapid weight loss.

END increased ULK1Ser757 phosphorylation above rest and BFR by ~37-51% (P<0.05).

Low-intensity endurance exercise can enhance specific autophagy-related signaling in inactive individuals.

Diabetic nephropathy significantly increases cardiovascular risk.

Monitoring cardiovascular health is crucial for T2D patients with diabetic nephropathy.

The Open Formulary group had a mean reduction in A1c of −2.7 ± 2.4, which was significantly greater than the Restrictive Formulary group's reduction of −0.74 ± 2.1.

Practitioners may consider that an open formulary can lead to better glycemic control in patients with type 2 diabetes.

The association between adiposity and cardiovascular events is linear above specific BMI thresholds.

Understanding BMI thresholds can help in assessing cardiovascular risk.

Total antioxidant capacity was significantly higher during the low-GI diet compared to the high-GI diet under fasting conditions, with total ORAC values of 11,736 +/- 668 vs. 10,381 +/- 612 micromol Trolox equivalents/l (P = 0.002).

Practitioners may consider recommending low-GI diets to enhance antioxidant capacity in overweight or obese individuals.

The area under the postprandial response curve for total ORAC and PCA-ORAC differed significantly between the low-GI and high-GI diets.

Practitioners should note the importance of glycemic index in postprandial antioxidant responses.

Enhancement in plasma total antioxidant capacity occurs within 1 week on a low-GI diet, before changes in other risk factors.

Practitioners may observe rapid benefits of low-GI diets on antioxidant levels in patients.

Gastrointestinal adverse events were more frequent with semaglutide (82.8%) compared to placebo (63.2%).

Clinicians should monitor for gastrointestinal side effects when prescribing semaglutide.

The most common adverse events with tirzepatide were gastrointestinal, primarily mild to moderate in severity.

Practitioners should monitor for gastrointestinal side effects in patients using tirzepatide.

Gastrointestinal adverse events were reported in 79.6% of the cagrilintide-semaglutide group and 39.9% in the placebo group.

Clinicians should monitor for gastrointestinal side effects in patients receiving cagrilintide-semaglutide.

Gastrointestinal adverse events were more common with oral semaglutide than with placebo (74.0% vs. 42.2%).

Clinicians should monitor for gastrointestinal side effects in patients taking oral semaglutide.

Gastrointestinal adverse effects were the most commonly reported side effects of retatrutide.

Clinicians should monitor for gastrointestinal side effects in patients treated with retatrutide.

The most common adverse events in the retatrutide groups were gastrointestinal and were mostly mild to moderate in severity.

Practitioners should monitor for gastrointestinal side effects in patients treated with retatrutide.

The study supports the hypothesis that early life exposures, indicated by birth weight, are associated with chronic diseases in adulthood.

Practitioners should consider the impact of early life factors, such as birth weight, on long-term health outcomes.

Women with birth weights > 10 lb have an age-adjusted odds ratio of 1.62 for being in the highest quintile of body mass index compared to those who weighed 7.1 to 8.5 lb at birth in NHS I.

Practitioners should be aware of the potential link between high birth weight and increased obesity risk in women.

Early life exposures affecting birth weight may be important in the development of hypertension and obesity in adults.

Practitioners should consider the impact of early life factors on long-term health outcomes in women.

Moderate weight gain is associated with lower odds of achieving a composite healthy aging outcome.

Weight management strategies may be crucial for promoting healthy aging.

About 14% caloric restriction for 2 years in healthy humans improved thymopoiesis.

Caloric restriction may enhance immune function in healthy individuals.

No significant differences were noted in muscle thickness of the biceps brachii between the two training groups.

Both training methods may lead to similar muscle thickness outcomes.

Resmetirom achieved resolution of steatohepatitis without worsening of fibrosis in 26%-30% of participants compared to 10% for placebo.

Resmetirom may be an effective treatment option for patients with MASH and moderate to advanced liver fibrosis.

Resmetirom improved fibrosis without worsening of steatohepatitis in 24%-26% of participants compared to 14% for placebo.

Resmetirom may help improve liver fibrosis in patients with MASH without worsening their condition.

BMI is negatively correlated with the expression levels of the long and short forms of UCP-3 (long: r = -0.53, P = 0.025; short: r = -0.46, P = 0.047).

Understanding the relationship between BMI and UCP-3 expression may help in developing strategies for managing energy expenditure.